Clinical trials recruiting for Breast Neoplasm

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
  NCT06672302 · Phase: Not specified · Ages: 40 Years and older · Sex: Female · 3 locations
• A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
  NCT06075810 · Phase: Phase 1 · Ages: 21 Years and older · Sex: All (male and female) · 4 locations
• CRYoablation for Small Tumors As Local Treatment - SIX Trial
  NCT06839001 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Cryoablation vs Lumpectomy in T1 Breast Cancers
  NCT05505643 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: Female · 1 location
• Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
  NCT07273812 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
  NCT06630962 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
  NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Health Economic Evaluation of an Adapted Physical Activity Program for Women With Breast Cancer
  NCT05949983 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction
  NCT06294574 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: Female · 1 location
• Improving Lifestyle Behavior by "Joven, Fuerte y Saludable" Multidisciplinary Program.
  NCT06090747 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 40 Years · Sex: Female · 1 location
• Magnetic Marker Localization for Occult Breast Cancer and Target Axillary Dissection in Node-positive Breast Cancer Post-neoadjuvant Chemotherapy
  NCT05427071 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
  NCT06058650 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer
  NCT03740893 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
  NCT01766297 · Phase: Phase 2 · Ages: 50 Years and older · Sex: Female · 9 locations
• Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
  NCT06805812 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 24 locations
• Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program
  NCT04652609 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Quantitative Microvasculature Imaging for Breast Cancer Detection and Monitoring
  NCT04799535 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• SNF Platform Study of HR+/ HER2-advanced Breast Cancer
  NCT05594095 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
  NCT06072612 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 79 locations
• Surviving Daily Life
  NCT07054723 · Phase: Not specified · Ages: 40 Years and older · Sex: Female · 1 location

Related conditions

Trials recruiting for Breast Neoplasm often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Breast Neoplasm trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.